Lataa...
RhoA/ROCK inhibition improves the beneficial effects of glucocorticoid treatment in dystrophic muscle: implications for stem cell depletion
Glucocorticoid treatment represents a standard palliative treatment for Duchenne muscular dystrophy (DMD) patients, but various adverse effects have limited this treatment. In an effort to understand the mechanism(s) by which glucocorticoids impart their effects on the dystrophic muscle, and potenti...
Tallennettuna:
| Julkaisussa: | Hum Mol Genet |
|---|---|
| Päätekijät: | , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Oxford University Press
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5886088/ https://ncbi.nlm.nih.gov/pubmed/28549178 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/hmg/ddx117 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|